Key result
Preoperative statins cut postoperative AF risk up to ~58% in CABG patients.
Why the study?
Accumulating evidence suggests that preoperative statin administration might help prevent adverse events after CABG, motivating a review of their role in perioperative management.
Does preoperative administration of statins improve perioperative outcomes in patients undergoing CABG?
Does preoperative administration of statins improve perioperative outcomes in patients undergoing CABG?
Preoperative statin administration, particularly high-dose atorvastatin, is recommended for patients undergoing CABG to reduce postoperative atrial fibrillation and length of stay.
Answers are grounded in this paper and cite their sources.
Supports preoperative statin consideration in CABG; leaves open definitive recommendations without randomized confirmation.
Each year, a large number of patients undergo coronary artery bypass grafting surgery (CABG) worldwide. Accumulating evidence suggests that the preoperative administration of statins might be useful in preventing adverse events after CABG. In the present review, we discuss the role of statins in the perioperative management of patients undergoing CABG. Preoperative administration of statins in these patients substantially reduces the risk of postoperative atrial fibrillation and shortens hospital and intensive care unit (ICU) stay. Atorvastatin appears to be more effective, particularly when administered at high doses. Given these benefits and the safety of statins, their administration should be considered in patients undergoing CABG, even though the statins do not appear to affect the incidence of cardiovascular events and overall mortality perioperatively.
No takes yet. Share an insight, caveat, or question.
Siskos et al. (2018) conducted a review in Coronary artery bypass grafting (CABG). Preoperative statins (e.g., atorvastatin, rosuvastatin) vs. Placebo or no preoperative statin was evaluated on Postoperative atrial fibrillation. Preoperative statin administration in CABG patients reduces postoperative atrial fibrillation risk by up to 58% and shortens hospital stay by ~0.5 days without affecting perioperative mortality.
Synapse has enriched 10 related papers. Consider them for comparative context: